# FDA recall D-1099-2020

> **Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy** · Class II · drug recall initiated 2020-03-26.

## Product

Alprostadil 10mcg/Papaverine 30mg/Phentolamine 1mg/ml lnj Soln, 5 mL, Injectable, Rx only, INNOVATIVE COMPOUNDING PHARMACY, 41536 EASTMAN DRIVE SUITE A MURRIETA , CA 92562  951-304-9530

## Reason for recall

Lack of Assurance of Sterility

## Distribution

Patient Distribution list includes addresses in the following states: CA, ME, TX

## Key facts

- **Recall number:** D-1099-2020
- **Recalling firm:** Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-03-26
- **Report date:** 2020-04-15
- **Termination date:** 2024-01-29

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Murrieta, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1099-2020

## Citation

> AI Analytics. FDA recall D-1099-2020. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-1099-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*